Chloride channel protein 3 (CLCN3)

Chloride channel protein 3 (CLCN3) is a member of the CLC family of voltage-gated chloride channels and chloride/proton exchangers, primarily functioning as a strongly outwardly rectifying, electrogenic H+/Cl− exchanger[9][7]. It is widely expressed in various tissues, including the nervous system, where it is present in synaptic vesicles and postsynaptic membranes. CLCN3 is critically involved in chloride ion transport, regulation of membrane potential, and cellular processes such as endosomal acidification, cell volume control, and synaptic plasticity. Loss of CLCN3 function in mice leads to selective neurodegeneration, indicating its importance in neuronal health[1]. In disease contexts, CLCN3 is implicated in cancer, particularly multiple myeloma and some solid tumors, likely via effects on cell migration and signaling pathways (e.g., PI3K/Akt/mTOR)[8]. Experimental evidence links CLCN3 to modulation of excitatory synaptic transmission and long-term potentiation via feedback loops involving NMDA receptors and CaMKII-mediated phosphorylation. Current drug interaction data are limited to research tools and pathway modulators; no clinical inhibitors are approved or well characterized as of the latest literature.

Other names

CLC-3CLCN3Chloride channel 3H+/Cl− exchange transporter 3

Modulation of chloride/proton exchange alters membrane excitability and cell signaling. Targeting CLCN3 can modulate synaptic plasticity by adjusting chloride flux, thereby affecting neuronal signaling pathways. Inhibition can reduce cell migration and invasion in cancer lines (via PI3K/Akt/mTOR pathway).